Company intelligence / Profile preview
LETI Pharma
Barcelona, Spainleti.com ↗
- Ownership
- Private
- Employees
- ~750
- Development stage
- Commercial
01
Overview
The company has commercial products in immunology, allergy, dermatology, and animal health. They have a vaccine against canine Leishmaniosis called LetiFend®.
- Therapeutic areas
- ImmunologyDermatologyInfectious Diseases
- Modalities
- Allergen extractsImmunotherapyVaccines
- Industry
- Biotech
02
Drug pipeline
47 assets46 more assets in the full pipeline.
03
Partnerships
MSD Animal Health (for distribution of LetiFend® vaccine in France, Italy, Greece, and soon Great Britain)partnerships with universities and research centers
Beyond the preview
Go deeper on LETI Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LETI Pharma.